Macher B A, Klock J C, Fukuda M N, Fukuda M
J Biol Chem. 1981 Feb 25;256(4):1968-74.
Gangliosides were isolated from purified preparations of human peripheral blood lymphocytes and neutrophils. Structural analyses and comparisons were performed by direct probe mass spectrometry and by degradation studies with the following enzymes: Escherichia freundii endo-beta-galactosidase; Clostridium perfringens and Arthrobacter ureafaciens neuraminidase; and jack bean beta-N-acetylhexosaminidase and beta-galactosidase. This combination of techniques allowed us to obtain carbohydrate composition and sequence information without the aid of methylation or carbohydrate compositional analyses using only 1-2 mg of purified gangliosides. On the basis of these studies we propose that human lymphocytes and neutrophils have gangliosides with the following structures. NeuAc alpha 2 leads to 3Gal beta 1 leads to 4Glc beta 1 leads to 1Cer Structure A NeuAc alpha 2 leads to ? GlcNAc beta 1 leads to 3Gal beta 1 leads to 4Glc beta 1 leads to 1Cer Structure B NeuAc alpha 2 leads to ? Gal beta 1 leads to 3,4GlcNAc beta 1 leads to 3Gal beta 1 leads to 4Glc beta 1 leads to 1Cer Structure C All three compounds were isolated from both cell types with structure A being the major lymphocyte ganglioside and structure C the major neutrophil ganglioside. Structure B is a novel ganglioside and may represent a leukocyte-specific glycosphingolipid. Neuraminidase degradation studies demonstrated that only one ganglioside species of each cell type contains an internally linked sialic acid residue, and on the basis of thin layer chromatographic analysis this component is the same as the major brain ganglioside, GM1 (II3-N-acetylneuraminosyl-gangliotetraosylceramide). In addition, large gangliosides with the general structure NeuAc alpha 2 leads to ?(Gal beta 1 leads to 3,4GlcNAc beta 1 leads to 3)n Gal beta 1 leads to 4Glc beta 1 leads to 1Cer were isolated. These results are discussed as they relate to blood group antigens and specific cell surface markers in human leukocytes.
从人外周血淋巴细胞和中性粒细胞的纯化制剂中分离出神经节苷脂。通过直接探针质谱法以及使用以下酶进行降解研究来进行结构分析和比较:弗氏埃希菌内切β-半乳糖苷酶;产气荚膜梭菌和脲放线杆菌神经氨酸酶;以及刀豆β-N-乙酰己糖胺酶和β-半乳糖苷酶。这种技术组合使我们仅使用1-2毫克纯化的神经节苷脂,无需甲基化或碳水化合物组成分析的帮助就能获得碳水化合物组成和序列信息。基于这些研究,我们提出人淋巴细胞和中性粒细胞具有以下结构的神经节苷脂。唾液酸α2连接到3半乳糖β1连接到4葡萄糖β1连接到1神经酰胺 结构A 唾液酸α2连接到? N-乙酰葡糖胺β1连接到3半乳糖β1连接到4葡萄糖β1连接到1神经酰胺 结构B 唾液酸α2连接到? 半乳糖β1连接到3,4-N-乙酰葡糖胺β1连接到3半乳糖β1连接到4葡萄糖β1连接到1神经酰胺 结构C 这三种化合物均从两种细胞类型中分离得到,结构A是主要的淋巴细胞神经节苷脂,结构C是主要的中性粒细胞神经节苷脂。结构B是一种新型神经节苷脂,可能代表一种白细胞特异性糖鞘脂。神经氨酸酶降解研究表明,每种细胞类型中只有一种神经节苷脂含有内部连接的唾液酸残基,基于薄层色谱分析,该成分与主要的脑苷脂GM1(II3-N-乙酰神经氨酸基-神经节四糖神经酰胺)相同。此外,还分离出了具有一般结构唾液酸α2连接到?(半乳糖β1连接到3,4-N-乙酰葡糖胺β1连接到3)n半乳糖β1连接到4葡萄糖β1连接到1神经酰胺的大神经节苷脂。讨论了这些结果与人类白细胞血型抗原和特定细胞表面标志物的关系。